Eiffel hires ex-PowderJect manager as COO
Wednesday, 15 October, 2003
Drug reengineering company Eiffel Technologies (ASX:EIF) has recruited former PowderJect technologies manager Dr Pascal Hickey as chief operating officer.
Hickey, who will be based at Eiffel's Sydney facilities, will be responsible for the company's R&D programs.
In a statement, Eiffel CEO Christine Cussen said Hickey's experience in pharmaceutical R&D would help the company further develop its technology. Hickey played a key role in the transition of PowderJect (now part of Chiron Corporation) from a small spin-off company from Oxford University to a mature and profitable company with 1500 employees, she said.
Antibiotic for drug-resistant bacteria found in plain sight
The antibiotic in question is an intermediate chemical in the natural process that produces the...
No clear link between paracetamol in pregnancy and autism/ADHD
Existing evidence does not clearly link paracetamol (acetaminophen) use during pregnancy with...
Light at night can increase heart disease risk
Being exposed to bright light at night can significantly increase your chances of developing...
